240
Participants
Start Date
July 26, 2013
Primary Completion Date
July 14, 2017
Study Completion Date
February 18, 2030
Interferon beta-1a
Administration once weekly via i.m. injections.
Fingolimod
"Administrated orally once daily:~0.5 mg capsule for patients over 40 kg or 0.25 mg capsule for patients 40 kg or less."
Placebo capsule
Matching placebo capsule required for double-dummy masking to blind formulations.
Placebo i.m. injection
Matching placebo i.m. injection required for double-dummy masking to blind formulations.
Novartis Investigative Site, Vienna
Novartis Investigative Site, Sofia
Novartis Investigative Site, Parkville
Novartis Investigative Site, Tallinn
Novartis Investigative Site, Belgrade
Novartis Investigative Site, Marseille
Novartis Investigative Site, Milan
Novartis Investigative Site, Gallarate
Novartis Investigative Site, Montichiari
Novartis Investigative Site, Madrid
Novartis Investigative Site, Málaga
Novartis Investigative Site, Osijek
Novartis Investigative Site, Toulouse
AMO Corporation, Tallahassee
Novartis Investigative Site, Bordeaux
University of Miami, Miami
Novartis Investigative Site, Montpellier
Novartis Investigative Site, Istanbul
UAB Childrens Hospital Harbor Center Neurology Dept, Birmingham
Novartis Investigative Site, Izmir
Novartis Investigative Site, Vigo
Novartis Investigative Site, Göttingen
Novartis Investigative Site, Seville
Novartis Investigative Site, Bochum
Novartis Investigative Site, Valencia
Wayne State University, Detroit
Novartis Investigative Site, Barakaldo
Novartis Investigative Site, Samsun
Novartis Investigative Site, Kharkiv
Novartis Investigative Site, Bari
Novartis Investigative Site, Freiburg im Breisgau
University of Utah Clinical Trials Office, Salt Lake City
Novartis Investigative Site, Cefalù
Childrens Hospital Los Angeles, Los Angeles
Novartis Investigative Site, Erlangen
UCSF, San Francisco
Novartis Investigative Site, Le Kremlin-Bicêtre
Novartis Investigative Site, Catania
Novartis Investigative Site, Moscow
Novartis Investigative Site, Moscow
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Novosibirsk
Massachusetts General Hospital, Boston
Robert Wood Johnson Medical School, New Brunswick
Childrens Hospital of Philadelphia, Philadelphia
Novartis Investigative Site, Belo Horizonte
Novartis Investigative Site, Rio de Janeiro
Novartis Investigative Site, São Paulo
Novartis Investigative Site, Goiânia
Novartis Investigative Site, Calgary
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Dresden
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Riga
Novartis Investigative Site, Kaunas
Novartis Investigative Site, Mexico City
Novartis Investigative Site, Distrito Federal
Novartis Investigative Site, Rotterdam
Novartis Investigative Site, Lodz
Novartis Investigative Site, Lublin
Novartis Investigative Site, Poznan
Novartis Investigative Site, Wroclaw
San Jorge Childrens Hospital, Santurce
Novartis Investigative Site, Bucharest
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Ankara
Novartis Investigative Site, Ankara
Novartis Investigative Site, West Midlands
Novartis Investigative Site, Edinburgh
Novartis Investigative Site, London
Novartis Investigative Site, London
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY